ZVRA logo

Zevra Therapeutics (ZVRA) Current Liabilities

Annual Current Liabilities

$73.72 M
+$61.70 M+513.16%

31 December 2023

ZVRA Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Liabilities

$34.48 M
+$4.03 M+13.24%

30 September 2024

ZVRA Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ZVRA Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+513.2%+58.8%
3 y3 years+878.2%+832.4%
5 y5 years+514.1%+231.3%

ZVRA Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+1642.8%-53.2%+1070.8%
5 y5 yearsat high+1642.8%-54.4%+1070.8%
alltimeall timeat high+1773.4%-54.4%+1070.8%

Zevra Therapeutics Current Liabilities History

DateAnnualQuarterly
Sept 2024
-
$34.48 M(+13.2%)
June 2024
-
$30.45 M(+1.8%)
Mar 2024
-
$29.91 M(-59.4%)
Dec 2023
$73.72 M(+513.2%)
$73.72 M(+239.5%)
Sept 2023
-
$21.71 M(+19.0%)
June 2023
-
$18.25 M(+16.9%)
Mar 2023
-
$15.62 M(+29.9%)
Dec 2022
$12.02 M(+184.2%)
$12.02 M(+42.6%)
Sept 2022
-
$8.43 M(+17.8%)
June 2022
-
$7.16 M(+143.1%)
Mar 2022
-
$2.94 M(-30.4%)
Dec 2021
$4.23 M(-43.9%)
-
Dec 2021
-
$4.23 M(+14.4%)
Sept 2021
-
$3.70 M(-37.9%)
June 2021
-
$5.96 M(+40.6%)
Mar 2021
-
$4.24 M(-43.8%)
Dec 2020
$7.54 M(+38.8%)
$7.54 M(-89.4%)
Sept 2020
-
$70.80 M(-2.4%)
June 2020
-
$72.55 M(-4.0%)
Mar 2020
-
$75.56 M(+1291.3%)
Dec 2019
$5.43 M
$5.43 M(-47.8%)
DateAnnualQuarterly
Sept 2019
-
$10.41 M(-30.5%)
June 2019
-
$14.97 M(-1.3%)
Mar 2019
-
$15.17 M(+26.4%)
Dec 2018
$12.00 M(+4.3%)
$12.00 M(-34.5%)
Sept 2018
-
$18.32 M(+4.1%)
June 2018
-
$17.60 M(+27.5%)
Mar 2018
-
$13.81 M(+20.0%)
Dec 2017
$11.51 M(+73.3%)
$11.51 M(+73.1%)
Sept 2017
-
$6.65 M(+0.8%)
June 2017
-
$6.59 M(+37.1%)
Mar 2017
-
$4.81 M(-27.6%)
Dec 2016
$6.64 M(-20.4%)
$6.64 M(+16.4%)
Sept 2016
-
$5.70 M(-22.8%)
June 2016
-
$7.39 M(+26.4%)
Mar 2016
-
$5.84 M(-29.9%)
Dec 2015
$8.34 M(+112.0%)
$8.34 M(+22.8%)
Sept 2015
-
$6.79 M(+38.3%)
June 2015
-
$4.91 M(+21.8%)
Mar 2015
-
$4.03 M(+2.5%)
Dec 2014
$3.94 M(-24.9%)
$3.94 M
Dec 2013
$5.24 M
-

FAQ

  • What is Zevra Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Zevra Therapeutics?
  • What is Zevra Therapeutics annual current liabilities year-on-year change?
  • What is Zevra Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Zevra Therapeutics?
  • What is Zevra Therapeutics quarterly current liabilities year-on-year change?

What is Zevra Therapeutics annual total current liabilities?

The current annual current liabilities of ZVRA is $73.72 M

What is the all time high annual current liabilities for Zevra Therapeutics?

Zevra Therapeutics all-time high annual total current liabilities is $73.72 M

What is Zevra Therapeutics annual current liabilities year-on-year change?

Over the past year, ZVRA annual total current liabilities has changed by +$61.70 M (+513.16%)

What is Zevra Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of ZVRA is $34.48 M

What is the all time high quarterly current liabilities for Zevra Therapeutics?

Zevra Therapeutics all-time high quarterly total current liabilities is $75.56 M

What is Zevra Therapeutics quarterly current liabilities year-on-year change?

Over the past year, ZVRA quarterly total current liabilities has changed by +$12.77 M (+58.80%)